Featured news

Nanologica AB’s (publ) (“Nanologica”) main owner Flerie Invest AB (“Flerie”) has today, May 23, 2025, made a mandatory cash offer of SEK 1.00 per share to the shareholders of Nanologica (the “Offer”). The offer is made in accordance with the rules on mandatory bid due to the acquisition of additional shares in Nanologica by Flerie on April 25, 2025. According to the Swedish Securities Council’s statement AMN 2024:62, Flerie received an exemption from the mandatory

Bulletin from the AGM 2025 Nanologica AB (publ) Nanologica AB (publ) today 22 May 2025 held its Annual General Meeting in Stockholm, at which the following resolutions were adopted. Adoption of the income statement and balance sheet, disposition of result The Annual General Meeting adopted the income statement and balance sheet for the company and the group in accordance with the presented accounting documents and resolved, in accordance with the board´s proposal, that the accumulated

Nanologica has received an order for the company’s silica-based purification media NLAB Saga® from a new customer in China. The customer is a large pharmaceutical manufacturer, and the order relates to evaluation of NLAB Saga® on a production scale. The order, which is worth USD 180,000, will be delivered during the second quarter. ”This is a highly interesting customer for us as it is larger than some of the others we work with. Among other

FINANCIAL SUMMARY Net sales for the first quarter amounted to SEK 10,751 thousand (5,037) The operating loss amounted to SEK 9,241 thousand (15,331) Loss after tax amounted to SEK 10,171 thousand (16,734) Earnings per share before and after dilution were SEK -0.12 (-0.46) Cash and cash equivalents per 31 March 2024 amounted to SEK 28,348 thousand (23,600). Shortly after the end of the quarter, the company’s cash and cash equivalents increased by approximately SEK 7